Ron Scarboro, Azurity Pharmaceuticals, claims drug reformulation that removes patient barriers must preserve efficacy, urging early cross-functional team alignment.
News|Articles|August 24, 2026
From Detection to Prediction: Modern Analytical Approaches for Nitrosamine Risk
Author(s)Chris Williams
Fact checked by: Ronald Panarotti
Nitrosamine control is about understanding why nitrosamines form, where they may form, and how to prevent their formation.
Advertisement
Advertisement
Nitrosamines have been known carcinogens for decades, but their emergence in pharmaceutical products in 2018 transformed them into a central regulatory and analytical priority.1 What began as a targeted investigation into a handful of small nitrosamines has since expanded into a complex, mechanism-driven discipline requiring predictive assessment, structural evaluation, and highly sensitive analytical methods.
Related to this article
PharmTech AI Pulse Check episode 2 covers AI data governance, API-gated journals, watermarking limits, and why attribution beats detection in GxP.
The FDA opened an expedited IND pilot, tightened scrutiny of foreign trial data, and finalized a rule recognizing non-animal testing methods. In Europe, the EMA advanced pharmaceutical legislation reform, restricted 2 legacy products, and opened an injectable-iron safety review.
Novartis licenses Abogen's mRNA-encoded T-cell engager for autoimmune disease, raising scale-up questions for mRNA-lipid nanoparticle manufacturing.
Pharma manufacturing spent 90 years learning that producing correct outputs isn't the same as catching your own errors. AI has only learned the first.
Ron Scarboro, Azurity Pharmaceuticals, explains why real-world usability belongs at product definition and how post-launch feedback should guide drug formulation.
Ronald Piervincenzi, USP, explains why drug supply resilience needs a system approach, from procurement benchmarks to regulatory capacity building.
Gene manufacturing platforms, patient-centric formulations, contract services, packaging innovations, and sterile filling lines are in the spotlight at CPHI Milan 2026.
Advertisement
Advertisement